William Sheremata

4.9k citations
73 papers · 3.7k · 1 hit paper · h-index 31

Impact in

Papers in

William Sheremata

69 papers receiving 3.5k citations

William Sheremata's Hit Papers

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis 2003 · 991 citations
9910+7+15Years since publication250500750

Peers

William Sheremata
Comparison fields: 5 of 112
  • Pathology and Forensic Medicine 1.4k
  • Immunology 1.4k
  • Neurology 717
  • Neurology 293
  • Agronomy and Crop Science 364
Replace Suhayl Dhib‐Jalbut with:
Suhayl Dhib‐Jalbut United States
Dale E. McFarlin United States
D. E. McFarlin United States
Takahiko Saida Japan
Irene Cortese United States
H. Link Sweden
Jan Lycke Sweden
Naganari Ohkura Japan
Norbert Goebels Germany
Avraham Ben‐Nun Israel
William Sheremata relative to Suhayl Dhib‐Jalbut United States Suhayl Dhib‐Jalbut's profile →
Citations per field
00.5×1.7×
Suhayl Dhib‐Jalbut · 1×
Citations per year

Countries citing papers authored by William Sheremata

Since Specialization
Citations

This map shows the geographic impact of William Sheremata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Sheremata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Sheremata more than expected).

Fields of papers citing papers by William Sheremata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Sheremata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Sheremata. The network helps show where William Sheremata may publish in the future.

Co-authors

The 25 scholars most cited alongside William Sheremata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William Sheremata Line = papers co-authored together William Sheremata links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Hit paper breakdown →
2003991
2 1985292
3 2008145
4 2004126
5 2011124
6 1971123
7 1988119
8 1989100
9 199999
10 199397
11 198681
12 198972
13
MR Imaging of Multiple Sclerosis: Comparison with Clinical and CT Examinations in 74 Patients
198568
14 200065
15 198462
16 199261
17 199154
18 197654
19 199252
20 199751

About William Sheremata

William Sheremata is a scholar working on Immunology, Pathology and Forensic Medicine, Neurology, Molecular Biology and Oncology, having authored 73 papers that have together received 3.7k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (23 papers), T-cell and Retrovirus Studies (14 papers), Peripheral Neuropathies and Disorders (12 papers), Macrophage Migration Inhibitory Factor (9 papers), Polyomavirus and related diseases (6 papers), Viral Infections and Immunology Research (6 papers), Vector-Borne Animal Diseases (4 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.4k citations), Immunology (1.4k citations), Neurology (717 citations), Neurology (293 citations) and Agronomy and Crop Science (364 citations). William Sheremata has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Alireza Minagar, Michele Libonati, Catherine M. Dalton, Omar Khan, Katherine Miszkiel, George P. Rice, Paul O’Connor, David H. Miller, Lance D. Blumhardt and Yeon S. Ahn. Their work appears in journals such as Neurology, AIDS Research and Human Retroviruses, Journal of the Neurological Sciences, Annals of Neurology and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact